Fractyl Health (GUTS) Shareholder's Equity (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 595,226.00
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 19.36 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 31.42 Bn
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 1.08 Bn
10 Fractyl Health 19.24 Mn 19.24 Mn - 21.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 21.38 Mn
Dec 31, 2025 9.46 Mn
Sep 30, 2025 -3.18 Mn
Jun 30, 2025 -18.21 Mn
Mar 31, 2025 6.38 Mn
Dec 31, 2024 28.42 Mn
Sep 30, 2024 50.32 Mn
Jun 30, 2024 70.76 Mn
Mar 31, 2024 84.18 Mn
Dec 31, 2023 -325.06 Mn
Sep 30, 2023 -307.18 Mn
Jun 30, 2023 -292.52 Mn
Mar 31, 2023 -263.39 Mn